script.reportAU
Metabolic

Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids

Brand: Neocate Syneo

PBAC's latest decision on Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids: Recommended (2024). Considered for Treatment of cows' milk protein enteropathy, severe cows' milk protein enteropathy with failure to thrive, combined intolerance to cows' milk protein/soy protein/protein hydrolysate formulae, IgE-mediated allergy to cows' milk protein and soy protein, cows' milk anaphylaxis, severe intestinal malabsorption including short bowel syndrome, and eosinophilic oesophagitis.

PBAC outcome
Recommended
Authority Required
ICER (AUD/QALY)
Not modelled
no economic evaluation
Submissions
2
first 2017
Submissions
2
2017 → 2024

Eligible population

Infants and children with cows' milk protein intolerance, cows' milk allergy, eosinophilic oesophagitis, severe intestinal malabsorption, or combined protein intolerances requiring amino acid-based formula.

Therapy area
Metabolic
Line of therapy
Not applicable
Evidence base
Cost-minimisation
Primary endpoint
Cost-minimisation
Economic model
Cost-minimisation
ICER note
No economic or financial analyses presented; cost-minimisation submission with no ICER calculated.

Submission history

Similar precedents

Open on full dashboard →